nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropinirole—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0368	0.0655	CbGbCtD
Ropinirole—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0346	0.0616	CbGbCtD
Ropinirole—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0346	0.0616	CbGbCtD
Ropinirole—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0313	0.0557	CbGbCtD
Ropinirole—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0303	0.054	CbGbCtD
Ropinirole—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0285	0.0507	CbGbCtD
Ropinirole—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0285	0.0507	CbGbCtD
Ropinirole—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0262	0.0467	CbGbCtD
Ropinirole—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0258	0.0459	CbGbCtD
Ropinirole—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0258	0.0459	CbGbCtD
Ropinirole—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0237	0.0422	CbGbCtD
Ropinirole—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0223	0.0396	CbGbCtD
Ropinirole—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0216	0.0384	CbGbCtD
Ropinirole—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0195	0.0348	CbGbCtD
Ropinirole—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0195	0.0348	CbGbCtD
Ropinirole—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0193	0.0343	CbGbCtD
Ropinirole—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0181	0.0323	CbGbCtD
Ropinirole—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0181	0.0323	CbGbCtD
Ropinirole—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0164	0.0292	CbGbCtD
Ropinirole—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0164	0.0292	CbGbCtD
Ropinirole—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0142	0.0252	CbGbCtD
Ropinirole—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0137	0.0244	CbGbCtD
Ropinirole—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0124	0.0221	CbGbCtD
Ropinirole—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0124	0.0221	CbGbCtD
Ropinirole—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0119	0.0212	CbGbCtD
Ropinirole—DRD1—nerve—acquired immunodeficiency syndrome	0.00311	0.0618	CbGeAlD
Ropinirole—DRD2—nerve—acquired immunodeficiency syndrome	0.00184	0.0365	CbGeAlD
Ropinirole—HTR1A—blood plasma—acquired immunodeficiency syndrome	0.00154	0.0306	CbGeAlD
Ropinirole—HTR2A—nerve—acquired immunodeficiency syndrome	0.00121	0.0241	CbGeAlD
Ropinirole—DRD5—lymphoid tissue—acquired immunodeficiency syndrome	0.0012	0.0238	CbGeAlD
Ropinirole—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.00117	0.0233	CbGeAlD
Ropinirole—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.00108	0.0214	CbGeAlD
Ropinirole—DRD4—brain—acquired immunodeficiency syndrome	0.00106	0.0211	CbGeAlD
Ropinirole—HTR2A—endothelium—acquired immunodeficiency syndrome	0.00103	0.0205	CbGeAlD
Ropinirole—DRD3—nervous system—acquired immunodeficiency syndrome	0.000976	0.0194	CbGeAlD
Ropinirole—DRD3—central nervous system—acquired immunodeficiency syndrome	0.000939	0.0187	CbGeAlD
Ropinirole—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.000916	0.0182	CbGeAlD
Ropinirole—DRD5—nervous system—acquired immunodeficiency syndrome	0.000914	0.0182	CbGeAlD
Ropinirole—DRD5—central nervous system—acquired immunodeficiency syndrome	0.00088	0.0175	CbGeAlD
Ropinirole—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000848	0.0169	CbGeAlD
Ropinirole—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000834	0.0166	CbGeAlD
Ropinirole—HTR2B—skin of body—acquired immunodeficiency syndrome	0.000824	0.0164	CbGeAlD
Ropinirole—DRD2—retina—acquired immunodeficiency syndrome	0.00076	0.0151	CbGeAlD
Ropinirole—DRD3—brain—acquired immunodeficiency syndrome	0.000746	0.0148	CbGeAlD
Ropinirole—DRD5—brain—acquired immunodeficiency syndrome	0.000699	0.0139	CbGeAlD
Ropinirole—DRD1—nervous system—acquired immunodeficiency syndrome	0.000699	0.0139	CbGeAlD
Ropinirole—DRD1—central nervous system—acquired immunodeficiency syndrome	0.000673	0.0134	CbGeAlD
Ropinirole—HTR1B—spinal cord—acquired immunodeficiency syndrome	0.000672	0.0134	CbGeAlD
Ropinirole—HTR2B—digestive system—acquired immunodeficiency syndrome	0.000659	0.0131	CbGeAlD
Ropinirole—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.000644	0.0128	CbGeAlD
Ropinirole—HTR2B—blood—acquired immunodeficiency syndrome	0.000628	0.0125	CbGeAlD
Ropinirole—HTR2B—vagina—acquired immunodeficiency syndrome	0.000582	0.0116	CbGeAlD
Ropinirole—HTR1B—nervous system—acquired immunodeficiency syndrome	0.000566	0.0113	CbGeAlD
Ropinirole—HTR2B—lung—acquired immunodeficiency syndrome	0.000551	0.011	CbGeAlD
Ropinirole—HTR1D—nervous system—acquired immunodeficiency syndrome	0.000548	0.0109	CbGeAlD
Ropinirole—HTR1B—central nervous system—acquired immunodeficiency syndrome	0.000545	0.0108	CbGeAlD
Ropinirole—HTR2C—nervous system—acquired immunodeficiency syndrome	0.000543	0.0108	CbGeAlD
Ropinirole—HTR1A—spinal cord—acquired immunodeficiency syndrome	0.000542	0.0108	CbGeAlD
Ropinirole—DRD1—brain—acquired immunodeficiency syndrome	0.000534	0.0106	CbGeAlD
Ropinirole—HTR1D—central nervous system—acquired immunodeficiency syndrome	0.000528	0.0105	CbGeAlD
Ropinirole—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.000523	0.0104	CbGeAlD
Ropinirole—HTR2B—nervous system—acquired immunodeficiency syndrome	0.00051	0.0101	CbGeAlD
Ropinirole—HTR2A—retina—acquired immunodeficiency syndrome	0.000501	0.00998	CbGeAlD
Ropinirole—ADRA2C—blood—acquired immunodeficiency syndrome	0.000494	0.00984	CbGeAlD
Ropinirole—HTR2B—central nervous system—acquired immunodeficiency syndrome	0.000491	0.00977	CbGeAlD
Ropinirole—ADRA2C—spinal cord—acquired immunodeficiency syndrome	0.000476	0.00948	CbGeAlD
Ropinirole—ADRA2C—vagina—acquired immunodeficiency syndrome	0.000458	0.00912	CbGeAlD
Ropinirole—HTR1A—nervous system—acquired immunodeficiency syndrome	0.000457	0.00909	CbGeAlD
Ropinirole—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.00045	0.00896	CbGeAlD
Ropinirole—DRD2—lung—acquired immunodeficiency syndrome	0.000446	0.00887	CbGeAlD
Ropinirole—HTR1A—central nervous system—acquired immunodeficiency syndrome	0.00044	0.00875	CbGeAlD
Ropinirole—ADRA2C—lung—acquired immunodeficiency syndrome	0.000433	0.00863	CbGeAlD
Ropinirole—HTR1B—brain—acquired immunodeficiency syndrome	0.000433	0.00861	CbGeAlD
Ropinirole—CYP1A2—blood—acquired immunodeficiency syndrome	0.000429	0.00854	CbGeAlD
Ropinirole—HTR1D—brain—acquired immunodeficiency syndrome	0.000419	0.00834	CbGeAlD
Ropinirole—HTR2C—brain—acquired immunodeficiency syndrome	0.000415	0.00826	CbGeAlD
Ropinirole—DRD2—nervous system—acquired immunodeficiency syndrome	0.000413	0.00822	CbGeAlD
Ropinirole—ADRA2C—nervous system—acquired immunodeficiency syndrome	0.000401	0.00799	CbGeAlD
Ropinirole—DRD2—central nervous system—acquired immunodeficiency syndrome	0.000397	0.00791	CbGeAlD
Ropinirole—ADRA2A—blood—acquired immunodeficiency syndrome	0.000394	0.00785	CbGeAlD
Ropinirole—HTR2B—brain—acquired immunodeficiency syndrome	0.00039	0.00776	CbGeAlD
Ropinirole—ADRA2C—central nervous system—acquired immunodeficiency syndrome	0.000386	0.00769	CbGeAlD
Ropinirole—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.00038	0.00756	CbGeAlD
Ropinirole—HTR2B—lymph node—acquired immunodeficiency syndrome	0.000377	0.00749	CbGeAlD
Ropinirole—CYP1A2—lung—acquired immunodeficiency syndrome	0.000376	0.00748	CbGeAlD
Ropinirole—ADRA2A—vagina—acquired immunodeficiency syndrome	0.000366	0.00728	CbGeAlD
Ropinirole—HTR2A—digestive system—acquired immunodeficiency syndrome	0.000352	0.00701	CbGeAlD
Ropinirole—HTR1A—brain—acquired immunodeficiency syndrome	0.000349	0.00695	CbGeAlD
Ropinirole—ADRA2A—lung—acquired immunodeficiency syndrome	0.000346	0.00688	CbGeAlD
Ropinirole—HTR2A—blood—acquired immunodeficiency syndrome	0.000335	0.00668	CbGeAlD
Ropinirole—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000326	0.00649	CbGeAlD
Ropinirole—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.000323	0.00643	CbGeAlD
Ropinirole—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000321	0.00638	CbGeAlD
Ropinirole—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.00032	0.00637	CbGeAlD
Ropinirole—DRD2—brain—acquired immunodeficiency syndrome	0.000316	0.00628	CbGeAlD
Ropinirole—HTR2A—vagina—acquired immunodeficiency syndrome	0.000311	0.00619	CbGeAlD
Ropinirole—CYP3A4—blood—acquired immunodeficiency syndrome	0.00031	0.00618	CbGeAlD
Ropinirole—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.000308	0.00614	CbGeAlD
Ropinirole—ADRA2C—brain—acquired immunodeficiency syndrome	0.000307	0.00611	CbGeAlD
Ropinirole—CYP2D6—blood—acquired immunodeficiency syndrome	0.000306	0.00608	CbGeAlD
Ropinirole—ADRA2C—lymph node—acquired immunodeficiency syndrome	0.000296	0.0059	CbGeAlD
Ropinirole—HTR2A—lung—acquired immunodeficiency syndrome	0.000294	0.00585	CbGeAlD
Ropinirole—HTR2A—nervous system—acquired immunodeficiency syndrome	0.000272	0.00542	CbGeAlD
Ropinirole—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.000262	0.00522	CbGeAlD
Ropinirole—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000252	0.00502	CbGeAlD
Ropinirole—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000248	0.00494	CbGeAlD
Ropinirole—ADRA2A—brain—acquired immunodeficiency syndrome	0.000245	0.00487	CbGeAlD
Ropinirole—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000243	0.00483	CbGeAlD
Ropinirole—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000239	0.00475	CbGeAlD
Ropinirole—ADRA2A—lymph node—acquired immunodeficiency syndrome	0.000236	0.00471	CbGeAlD
Ropinirole—HTR2A—brain—acquired immunodeficiency syndrome	0.000208	0.00414	CbGeAlD
Ropinirole—CYP2D6—brain—acquired immunodeficiency syndrome	0.00019	0.00377	CbGeAlD
Ropinirole—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	7.64e-05	0.000234	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	7.63e-05	0.000233	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	7.61e-05	0.000233	CcSEcCtD
Ropinirole—Pruritus—Abacavir—acquired immunodeficiency syndrome	7.6e-05	0.000232	CcSEcCtD
Ropinirole—Fatigue—Indinavir—acquired immunodeficiency syndrome	7.6e-05	0.000232	CcSEcCtD
Ropinirole—Anorexia—Delavirdine—acquired immunodeficiency syndrome	7.59e-05	0.000232	CcSEcCtD
Ropinirole—Discomfort—Ritonavir—acquired immunodeficiency syndrome	7.59e-05	0.000232	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	7.59e-05	0.000232	CcSEcCtD
Ropinirole—Cough—Saquinavir—acquired immunodeficiency syndrome	7.58e-05	0.000232	CcSEcCtD
Ropinirole—Angioedema—Lamivudine—acquired immunodeficiency syndrome	7.57e-05	0.000232	CcSEcCtD
Ropinirole—Pain—Indinavir—acquired immunodeficiency syndrome	7.54e-05	0.00023	CcSEcCtD
Ropinirole—Constipation—Indinavir—acquired immunodeficiency syndrome	7.54e-05	0.00023	CcSEcCtD
Ropinirole—Insomnia—Efavirenz—acquired immunodeficiency syndrome	7.53e-05	0.00023	CcSEcCtD
Ropinirole—Urticaria—Zidovudine—acquired immunodeficiency syndrome	7.53e-05	0.00023	CcSEcCtD
Ropinirole—Convulsion—Saquinavir—acquired immunodeficiency syndrome	7.53e-05	0.00023	CcSEcCtD
Ropinirole—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	7.52e-05	0.00023	CcSEcCtD
Ropinirole—Hypertension—Saquinavir—acquired immunodeficiency syndrome	7.5e-05	0.000229	CcSEcCtD
Ropinirole—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	7.49e-05	0.000229	CcSEcCtD
Ropinirole—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	7.49e-05	0.000229	CcSEcCtD
Ropinirole—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	7.48e-05	0.000229	CcSEcCtD
Ropinirole—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	7.48e-05	0.000229	CcSEcCtD
Ropinirole—Malaise—Lamivudine—acquired immunodeficiency syndrome	7.47e-05	0.000229	CcSEcCtD
Ropinirole—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	7.46e-05	0.000228	CcSEcCtD
Ropinirole—Nausea—Didanosine—acquired immunodeficiency syndrome	7.46e-05	0.000228	CcSEcCtD
Ropinirole—Vertigo—Lamivudine—acquired immunodeficiency syndrome	7.45e-05	0.000228	CcSEcCtD
Ropinirole—Hypotension—Delavirdine—acquired immunodeficiency syndrome	7.44e-05	0.000228	CcSEcCtD
Ropinirole—Syncope—Lamivudine—acquired immunodeficiency syndrome	7.43e-05	0.000227	CcSEcCtD
Ropinirole—Confusional state—Ritonavir—acquired immunodeficiency syndrome	7.43e-05	0.000227	CcSEcCtD
Ropinirole—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	7.42e-05	0.000227	CcSEcCtD
Ropinirole—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	7.42e-05	0.000227	CcSEcCtD
Ropinirole—Somnolence—Efavirenz—acquired immunodeficiency syndrome	7.4e-05	0.000226	CcSEcCtD
Ropinirole—Chest pain—Saquinavir—acquired immunodeficiency syndrome	7.4e-05	0.000226	CcSEcCtD
Ropinirole—Myalgia—Saquinavir—acquired immunodeficiency syndrome	7.4e-05	0.000226	CcSEcCtD
Ropinirole—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	7.4e-05	0.000226	CcSEcCtD
Ropinirole—Anxiety—Saquinavir—acquired immunodeficiency syndrome	7.37e-05	0.000225	CcSEcCtD
Ropinirole—Oedema—Ritonavir—acquired immunodeficiency syndrome	7.37e-05	0.000225	CcSEcCtD
Ropinirole—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	7.35e-05	0.000225	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	7.35e-05	0.000225	CcSEcCtD
Ropinirole—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	7.33e-05	0.000224	CcSEcCtD
Ropinirole—Discomfort—Saquinavir—acquired immunodeficiency syndrome	7.31e-05	0.000224	CcSEcCtD
Ropinirole—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	7.28e-05	0.000223	CcSEcCtD
Ropinirole—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	7.26e-05	0.000222	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	7.26e-05	0.000222	CcSEcCtD
Ropinirole—Shock—Ritonavir—acquired immunodeficiency syndrome	7.25e-05	0.000222	CcSEcCtD
Ropinirole—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	7.24e-05	0.000221	CcSEcCtD
Ropinirole—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	7.23e-05	0.000221	CcSEcCtD
Ropinirole—Cough—Lamivudine—acquired immunodeficiency syndrome	7.23e-05	0.000221	CcSEcCtD
Ropinirole—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	7.23e-05	0.000221	CcSEcCtD
Ropinirole—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	7.22e-05	0.000221	CcSEcCtD
Ropinirole—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	7.21e-05	0.000221	CcSEcCtD
Ropinirole—Dizziness—Stavudine—acquired immunodeficiency syndrome	7.21e-05	0.00022	CcSEcCtD
Ropinirole—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	7.21e-05	0.00022	CcSEcCtD
Ropinirole—Insomnia—Delavirdine—acquired immunodeficiency syndrome	7.21e-05	0.00022	CcSEcCtD
Ropinirole—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	7.19e-05	0.00022	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	7.19e-05	0.00022	CcSEcCtD
Ropinirole—Convulsion—Lamivudine—acquired immunodeficiency syndrome	7.18e-05	0.00022	CcSEcCtD
Ropinirole—Vomiting—Nevirapine—acquired immunodeficiency syndrome	7.18e-05	0.00022	CcSEcCtD
Ropinirole—Fatigue—Efavirenz—acquired immunodeficiency syndrome	7.18e-05	0.00022	CcSEcCtD
Ropinirole—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	7.16e-05	0.000219	CcSEcCtD
Ropinirole—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	7.15e-05	0.000219	CcSEcCtD
Ropinirole—Confusional state—Saquinavir—acquired immunodeficiency syndrome	7.15e-05	0.000219	CcSEcCtD
Ropinirole—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	7.12e-05	0.000218	CcSEcCtD
Ropinirole—Pain—Efavirenz—acquired immunodeficiency syndrome	7.12e-05	0.000218	CcSEcCtD
Ropinirole—Constipation—Efavirenz—acquired immunodeficiency syndrome	7.12e-05	0.000218	CcSEcCtD
Ropinirole—Rash—Nevirapine—acquired immunodeficiency syndrome	7.12e-05	0.000218	CcSEcCtD
Ropinirole—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	7.11e-05	0.000218	CcSEcCtD
Ropinirole—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	7.1e-05	0.000217	CcSEcCtD
Ropinirole—Dizziness—Abacavir—acquired immunodeficiency syndrome	7.1e-05	0.000217	CcSEcCtD
Ropinirole—Oedema—Saquinavir—acquired immunodeficiency syndrome	7.09e-05	0.000217	CcSEcCtD
Ropinirole—Somnolence—Delavirdine—acquired immunodeficiency syndrome	7.08e-05	0.000217	CcSEcCtD
Ropinirole—Headache—Nevirapine—acquired immunodeficiency syndrome	7.07e-05	0.000216	CcSEcCtD
Ropinirole—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	7.06e-05	0.000216	CcSEcCtD
Ropinirole—Chest pain—Lamivudine—acquired immunodeficiency syndrome	7.06e-05	0.000216	CcSEcCtD
Ropinirole—Myalgia—Lamivudine—acquired immunodeficiency syndrome	7.06e-05	0.000216	CcSEcCtD
Ropinirole—Infection—Saquinavir—acquired immunodeficiency syndrome	7.04e-05	0.000215	CcSEcCtD
Ropinirole—Anxiety—Lamivudine—acquired immunodeficiency syndrome	7.03e-05	0.000215	CcSEcCtD
Ropinirole—Anorexia—Ritonavir—acquired immunodeficiency syndrome	7.02e-05	0.000215	CcSEcCtD
Ropinirole—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	7.01e-05	0.000214	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	7.01e-05	0.000214	CcSEcCtD
Ropinirole—Urticaria—Indinavir—acquired immunodeficiency syndrome	7e-05	0.000214	CcSEcCtD
Ropinirole—Shock—Saquinavir—acquired immunodeficiency syndrome	6.98e-05	0.000213	CcSEcCtD
Ropinirole—Discomfort—Lamivudine—acquired immunodeficiency syndrome	6.97e-05	0.000213	CcSEcCtD
Ropinirole—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	6.97e-05	0.000213	CcSEcCtD
Ropinirole—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	6.97e-05	0.000213	CcSEcCtD
Ropinirole—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	6.95e-05	0.000213	CcSEcCtD
Ropinirole—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	6.95e-05	0.000213	CcSEcCtD
Ropinirole—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	6.94e-05	0.000212	CcSEcCtD
Ropinirole—Vomiting—Stavudine—acquired immunodeficiency syndrome	6.93e-05	0.000212	CcSEcCtD
Ropinirole—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	6.92e-05	0.000212	CcSEcCtD
Ropinirole—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	6.9e-05	0.000211	CcSEcCtD
Ropinirole—Rash—Nelfinavir—acquired immunodeficiency syndrome	6.89e-05	0.000211	CcSEcCtD
Ropinirole—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	6.89e-05	0.000211	CcSEcCtD
Ropinirole—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	6.89e-05	0.000211	CcSEcCtD
Ropinirole—Hypotension—Ritonavir—acquired immunodeficiency syndrome	6.88e-05	0.000211	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	6.88e-05	0.00021	CcSEcCtD
Ropinirole—Rash—Stavudine—acquired immunodeficiency syndrome	6.87e-05	0.00021	CcSEcCtD
Ropinirole—Fatigue—Delavirdine—acquired immunodeficiency syndrome	6.87e-05	0.00021	CcSEcCtD
Ropinirole—Dermatitis—Stavudine—acquired immunodeficiency syndrome	6.87e-05	0.00021	CcSEcCtD
Ropinirole—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	6.86e-05	0.00021	CcSEcCtD
Ropinirole—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	6.85e-05	0.00021	CcSEcCtD
Ropinirole—Headache—Nelfinavir—acquired immunodeficiency syndrome	6.85e-05	0.00021	CcSEcCtD
Ropinirole—Headache—Stavudine—acquired immunodeficiency syndrome	6.83e-05	0.000209	CcSEcCtD
Ropinirole—Vomiting—Abacavir—acquired immunodeficiency syndrome	6.83e-05	0.000209	CcSEcCtD
Ropinirole—Confusional state—Lamivudine—acquired immunodeficiency syndrome	6.82e-05	0.000209	CcSEcCtD
Ropinirole—Pain—Delavirdine—acquired immunodeficiency syndrome	6.81e-05	0.000208	CcSEcCtD
Ropinirole—Constipation—Delavirdine—acquired immunodeficiency syndrome	6.81e-05	0.000208	CcSEcCtD
Ropinirole—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	6.81e-05	0.000208	CcSEcCtD
Ropinirole—Asthenia—Zidovudine—acquired immunodeficiency syndrome	6.8e-05	0.000208	CcSEcCtD
Ropinirole—Rash—Abacavir—acquired immunodeficiency syndrome	6.77e-05	0.000207	CcSEcCtD
Ropinirole—Dermatitis—Abacavir—acquired immunodeficiency syndrome	6.77e-05	0.000207	CcSEcCtD
Ropinirole—Oedema—Lamivudine—acquired immunodeficiency syndrome	6.76e-05	0.000207	CcSEcCtD
Ropinirole—Anorexia—Saquinavir—acquired immunodeficiency syndrome	6.76e-05	0.000207	CcSEcCtD
Ropinirole—Headache—Abacavir—acquired immunodeficiency syndrome	6.73e-05	0.000206	CcSEcCtD
Ropinirole—Infection—Lamivudine—acquired immunodeficiency syndrome	6.72e-05	0.000206	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	6.71e-05	0.000205	CcSEcCtD
Ropinirole—Nausea—Nevirapine—acquired immunodeficiency syndrome	6.71e-05	0.000205	CcSEcCtD
Ropinirole—Pruritus—Zidovudine—acquired immunodeficiency syndrome	6.7e-05	0.000205	CcSEcCtD
Ropinirole—Insomnia—Ritonavir—acquired immunodeficiency syndrome	6.66e-05	0.000204	CcSEcCtD
Ropinirole—Shock—Lamivudine—acquired immunodeficiency syndrome	6.65e-05	0.000204	CcSEcCtD
Ropinirole—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	6.63e-05	0.000203	CcSEcCtD
Ropinirole—Hypotension—Saquinavir—acquired immunodeficiency syndrome	6.63e-05	0.000203	CcSEcCtD
Ropinirole—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	6.62e-05	0.000203	CcSEcCtD
Ropinirole—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	6.61e-05	0.000202	CcSEcCtD
Ropinirole—Urticaria—Efavirenz—acquired immunodeficiency syndrome	6.61e-05	0.000202	CcSEcCtD
Ropinirole—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	6.58e-05	0.000201	CcSEcCtD
Ropinirole—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	6.58e-05	0.000201	CcSEcCtD
Ropinirole—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	6.57e-05	0.000201	CcSEcCtD
Ropinirole—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	6.57e-05	0.000201	CcSEcCtD
Ropinirole—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	6.56e-05	0.000201	CcSEcCtD
Ropinirole—Somnolence—Ritonavir—acquired immunodeficiency syndrome	6.55e-05	0.0002	CcSEcCtD
Ropinirole—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	6.54e-05	0.0002	CcSEcCtD
Ropinirole—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	6.51e-05	0.000199	CcSEcCtD
Ropinirole—Nausea—Nelfinavir—acquired immunodeficiency syndrome	6.5e-05	0.000199	CcSEcCtD
Ropinirole—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	6.49e-05	0.000199	CcSEcCtD
Ropinirole—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	6.48e-05	0.000198	CcSEcCtD
Ropinirole—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	6.48e-05	0.000198	CcSEcCtD
Ropinirole—Nausea—Stavudine—acquired immunodeficiency syndrome	6.48e-05	0.000198	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	6.46e-05	0.000198	CcSEcCtD
Ropinirole—Anorexia—Lamivudine—acquired immunodeficiency syndrome	6.45e-05	0.000197	CcSEcCtD
Ropinirole—Insomnia—Saquinavir—acquired immunodeficiency syndrome	6.41e-05	0.000196	CcSEcCtD
Ropinirole—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	6.4e-05	0.000196	CcSEcCtD
Ropinirole—Nausea—Abacavir—acquired immunodeficiency syndrome	6.38e-05	0.000195	CcSEcCtD
Ropinirole—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	6.37e-05	0.000195	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	6.36e-05	0.000195	CcSEcCtD
Ropinirole—Fatigue—Ritonavir—acquired immunodeficiency syndrome	6.35e-05	0.000194	CcSEcCtD
Ropinirole—Urticaria—Delavirdine—acquired immunodeficiency syndrome	6.33e-05	0.000194	CcSEcCtD
Ropinirole—Asthenia—Indinavir—acquired immunodeficiency syndrome	6.32e-05	0.000193	CcSEcCtD
Ropinirole—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	6.32e-05	0.000193	CcSEcCtD
Ropinirole—Hypotension—Lamivudine—acquired immunodeficiency syndrome	6.32e-05	0.000193	CcSEcCtD
Ropinirole—Somnolence—Saquinavir—acquired immunodeficiency syndrome	6.3e-05	0.000193	CcSEcCtD
Ropinirole—Constipation—Ritonavir—acquired immunodeficiency syndrome	6.3e-05	0.000193	CcSEcCtD
Ropinirole—Pain—Ritonavir—acquired immunodeficiency syndrome	6.3e-05	0.000193	CcSEcCtD
Ropinirole—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	6.3e-05	0.000193	CcSEcCtD
Ropinirole—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	6.3e-05	0.000193	CcSEcCtD
Ropinirole—Dizziness—Zidovudine—acquired immunodeficiency syndrome	6.27e-05	0.000192	CcSEcCtD
Ropinirole—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	6.24e-05	0.000191	CcSEcCtD
Ropinirole—Pruritus—Indinavir—acquired immunodeficiency syndrome	6.23e-05	0.000191	CcSEcCtD
Ropinirole—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	6.16e-05	0.000189	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	6.16e-05	0.000188	CcSEcCtD
Ropinirole—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	6.13e-05	0.000188	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	6.12e-05	0.000187	CcSEcCtD
Ropinirole—Insomnia—Lamivudine—acquired immunodeficiency syndrome	6.12e-05	0.000187	CcSEcCtD
Ropinirole—Fatigue—Saquinavir—acquired immunodeficiency syndrome	6.11e-05	0.000187	CcSEcCtD
Ropinirole—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	6.07e-05	0.000186	CcSEcCtD
Ropinirole—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	6.07e-05	0.000186	CcSEcCtD
Ropinirole—Constipation—Saquinavir—acquired immunodeficiency syndrome	6.06e-05	0.000185	CcSEcCtD
Ropinirole—Pain—Saquinavir—acquired immunodeficiency syndrome	6.06e-05	0.000185	CcSEcCtD
Ropinirole—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	6.03e-05	0.000184	CcSEcCtD
Ropinirole—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	6.03e-05	0.000184	CcSEcCtD
Ropinirole—Vomiting—Zidovudine—acquired immunodeficiency syndrome	6.02e-05	0.000184	CcSEcCtD
Ropinirole—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	6.02e-05	0.000184	CcSEcCtD
Ropinirole—Somnolence—Lamivudine—acquired immunodeficiency syndrome	6.01e-05	0.000184	CcSEcCtD
Ropinirole—Rash—Zidovudine—acquired immunodeficiency syndrome	5.97e-05	0.000183	CcSEcCtD
Ropinirole—Asthenia—Efavirenz—acquired immunodeficiency syndrome	5.97e-05	0.000183	CcSEcCtD
Ropinirole—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	5.97e-05	0.000183	CcSEcCtD
Ropinirole—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	5.95e-05	0.000182	CcSEcCtD
Ropinirole—Headache—Zidovudine—acquired immunodeficiency syndrome	5.94e-05	0.000182	CcSEcCtD
Ropinirole—Pruritus—Efavirenz—acquired immunodeficiency syndrome	5.89e-05	0.00018	CcSEcCtD
Ropinirole—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	5.88e-05	0.00018	CcSEcCtD
Ropinirole—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	5.87e-05	0.00018	CcSEcCtD
Ropinirole—Urticaria—Ritonavir—acquired immunodeficiency syndrome	5.85e-05	0.000179	CcSEcCtD
Ropinirole—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	5.84e-05	0.000179	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	5.84e-05	0.000179	CcSEcCtD
Ropinirole—Fatigue—Lamivudine—acquired immunodeficiency syndrome	5.83e-05	0.000178	CcSEcCtD
Ropinirole—Dizziness—Indinavir—acquired immunodeficiency syndrome	5.83e-05	0.000178	CcSEcCtD
Ropinirole—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	5.82e-05	0.000178	CcSEcCtD
Ropinirole—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	5.82e-05	0.000178	CcSEcCtD
Ropinirole—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	5.8e-05	0.000177	CcSEcCtD
Ropinirole—Pain—Lamivudine—acquired immunodeficiency syndrome	5.78e-05	0.000177	CcSEcCtD
Ropinirole—Constipation—Lamivudine—acquired immunodeficiency syndrome	5.78e-05	0.000177	CcSEcCtD
Ropinirole—Asthenia—Delavirdine—acquired immunodeficiency syndrome	5.72e-05	0.000175	CcSEcCtD
Ropinirole—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	5.7e-05	0.000174	CcSEcCtD
Ropinirole—Pruritus—Delavirdine—acquired immunodeficiency syndrome	5.64e-05	0.000172	CcSEcCtD
Ropinirole—Urticaria—Saquinavir—acquired immunodeficiency syndrome	5.63e-05	0.000172	CcSEcCtD
Ropinirole—Nausea—Zidovudine—acquired immunodeficiency syndrome	5.63e-05	0.000172	CcSEcCtD
Ropinirole—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	5.61e-05	0.000171	CcSEcCtD
Ropinirole—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	5.61e-05	0.000171	CcSEcCtD
Ropinirole—Vomiting—Indinavir—acquired immunodeficiency syndrome	5.6e-05	0.000171	CcSEcCtD
Ropinirole—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	5.57e-05	0.00017	CcSEcCtD
Ropinirole—Rash—Indinavir—acquired immunodeficiency syndrome	5.56e-05	0.00017	CcSEcCtD
Ropinirole—Dermatitis—Indinavir—acquired immunodeficiency syndrome	5.55e-05	0.00017	CcSEcCtD
Ropinirole—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	5.53e-05	0.000169	CcSEcCtD
Ropinirole—Headache—Indinavir—acquired immunodeficiency syndrome	5.52e-05	0.000169	CcSEcCtD
Ropinirole—Dizziness—Efavirenz—acquired immunodeficiency syndrome	5.51e-05	0.000168	CcSEcCtD
Ropinirole—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	5.45e-05	0.000167	CcSEcCtD
Ropinirole—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	5.43e-05	0.000166	CcSEcCtD
Ropinirole—Urticaria—Lamivudine—acquired immunodeficiency syndrome	5.37e-05	0.000164	CcSEcCtD
Ropinirole—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	5.35e-05	0.000164	CcSEcCtD
Ropinirole—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	5.35e-05	0.000164	CcSEcCtD
Ropinirole—Vomiting—Efavirenz—acquired immunodeficiency syndrome	5.29e-05	0.000162	CcSEcCtD
Ropinirole—Asthenia—Ritonavir—acquired immunodeficiency syndrome	5.29e-05	0.000162	CcSEcCtD
Ropinirole—Dizziness—Delavirdine—acquired immunodeficiency syndrome	5.27e-05	0.000161	CcSEcCtD
Ropinirole—Rash—Efavirenz—acquired immunodeficiency syndrome	5.25e-05	0.000161	CcSEcCtD
Ropinirole—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	5.24e-05	0.00016	CcSEcCtD
Ropinirole—Nausea—Indinavir—acquired immunodeficiency syndrome	5.23e-05	0.00016	CcSEcCtD
Ropinirole—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	5.22e-05	0.00016	CcSEcCtD
Ropinirole—Headache—Efavirenz—acquired immunodeficiency syndrome	5.22e-05	0.00016	CcSEcCtD
Ropinirole—Pruritus—Ritonavir—acquired immunodeficiency syndrome	5.21e-05	0.000159	CcSEcCtD
Ropinirole—Asthenia—Saquinavir—acquired immunodeficiency syndrome	5.09e-05	0.000156	CcSEcCtD
Ropinirole—Vomiting—Delavirdine—acquired immunodeficiency syndrome	5.07e-05	0.000155	CcSEcCtD
Ropinirole—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	5.04e-05	0.000154	CcSEcCtD
Ropinirole—Rash—Delavirdine—acquired immunodeficiency syndrome	5.02e-05	0.000154	CcSEcCtD
Ropinirole—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	5.02e-05	0.000153	CcSEcCtD
Ropinirole—Pruritus—Saquinavir—acquired immunodeficiency syndrome	5.02e-05	0.000153	CcSEcCtD
Ropinirole—Headache—Delavirdine—acquired immunodeficiency syndrome	4.99e-05	0.000153	CcSEcCtD
Ropinirole—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	4.98e-05	0.000152	CcSEcCtD
Ropinirole—Nausea—Efavirenz—acquired immunodeficiency syndrome	4.95e-05	0.000151	CcSEcCtD
Ropinirole—Dizziness—Ritonavir—acquired immunodeficiency syndrome	4.87e-05	0.000149	CcSEcCtD
Ropinirole—Asthenia—Lamivudine—acquired immunodeficiency syndrome	4.85e-05	0.000148	CcSEcCtD
Ropinirole—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	4.85e-05	0.000148	CcSEcCtD
Ropinirole—Pruritus—Lamivudine—acquired immunodeficiency syndrome	4.79e-05	0.000146	CcSEcCtD
Ropinirole—Nausea—Delavirdine—acquired immunodeficiency syndrome	4.73e-05	0.000145	CcSEcCtD
Ropinirole—Dizziness—Saquinavir—acquired immunodeficiency syndrome	4.69e-05	0.000143	CcSEcCtD
Ropinirole—Vomiting—Ritonavir—acquired immunodeficiency syndrome	4.68e-05	0.000143	CcSEcCtD
Ropinirole—Rash—Ritonavir—acquired immunodeficiency syndrome	4.64e-05	0.000142	CcSEcCtD
Ropinirole—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	4.64e-05	0.000142	CcSEcCtD
Ropinirole—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	4.63e-05	0.000142	CcSEcCtD
Ropinirole—Headache—Ritonavir—acquired immunodeficiency syndrome	4.61e-05	0.000141	CcSEcCtD
Ropinirole—Vomiting—Saquinavir—acquired immunodeficiency syndrome	4.51e-05	0.000138	CcSEcCtD
Ropinirole—Dizziness—Lamivudine—acquired immunodeficiency syndrome	4.47e-05	0.000137	CcSEcCtD
Ropinirole—Rash—Saquinavir—acquired immunodeficiency syndrome	4.47e-05	0.000137	CcSEcCtD
Ropinirole—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	4.47e-05	0.000137	CcSEcCtD
Ropinirole—Headache—Saquinavir—acquired immunodeficiency syndrome	4.44e-05	0.000136	CcSEcCtD
Ropinirole—Nausea—Ritonavir—acquired immunodeficiency syndrome	4.38e-05	0.000134	CcSEcCtD
Ropinirole—Vomiting—Lamivudine—acquired immunodeficiency syndrome	4.3e-05	0.000132	CcSEcCtD
Ropinirole—Rash—Lamivudine—acquired immunodeficiency syndrome	4.26e-05	0.00013	CcSEcCtD
Ropinirole—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	4.26e-05	0.00013	CcSEcCtD
Ropinirole—Headache—Lamivudine—acquired immunodeficiency syndrome	4.24e-05	0.00013	CcSEcCtD
Ropinirole—Nausea—Saquinavir—acquired immunodeficiency syndrome	4.21e-05	0.000129	CcSEcCtD
Ropinirole—Nausea—Lamivudine—acquired immunodeficiency syndrome	4.02e-05	0.000123	CcSEcCtD
Ropinirole—HTR1B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.01e-05	0.000497	CbGpPWpGaD
Ropinirole—HTR2A—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	3.01e-05	0.000496	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3e-05	0.000495	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.99e-05	0.000493	CbGpPWpGaD
Ropinirole—DRD4—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.96e-05	0.000489	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.96e-05	0.000488	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.96e-05	0.000488	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.96e-05	0.000488	CbGpPWpGaD
Ropinirole—ADRA2B—Hemostasis—ALB—acquired immunodeficiency syndrome	2.95e-05	0.000487	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.94e-05	0.000485	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.94e-05	0.000485	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.94e-05	0.000485	CbGpPWpGaD
Ropinirole—DRD1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.94e-05	0.000484	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.92e-05	0.000482	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.92e-05	0.000481	CbGpPWpGaD
Ropinirole—ADRA2B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.9e-05	0.000479	CbGpPWpGaD
Ropinirole—DRD3—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.9e-05	0.000478	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	2.9e-05	0.000478	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	2.9e-05	0.000478	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.89e-05	0.000477	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.89e-05	0.000477	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	2.88e-05	0.000476	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.88e-05	0.000475	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—TAT—acquired immunodeficiency syndrome	2.87e-05	0.000474	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.87e-05	0.000473	CbGpPWpGaD
Ropinirole—ADRA2B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.86e-05	0.000472	CbGpPWpGaD
Ropinirole—HTR2B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.83e-05	0.000466	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.82e-05	0.000465	CbGpPWpGaD
Ropinirole—HTR1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.8e-05	0.000462	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.8e-05	0.000461	CbGpPWpGaD
Ropinirole—HTR2C—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.79e-05	0.00046	CbGpPWpGaD
Ropinirole—HTR1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.76e-05	0.000455	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.76e-05	0.000455	CbGpPWpGaD
Ropinirole—ADRA2C—Hemostasis—ALB—acquired immunodeficiency syndrome	2.76e-05	0.000454	CbGpPWpGaD
Ropinirole—HTR2C—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.75e-05	0.000453	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.72e-05	0.000448	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.71e-05	0.000447	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.7e-05	0.000446	CbGpPWpGaD
Ropinirole—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.68e-05	0.000442	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.68e-05	0.000441	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.67e-05	0.000441	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.67e-05	0.00044	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.67e-05	0.00044	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.65e-05	0.000437	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.65e-05	0.000437	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.64e-05	0.000435	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.63e-05	0.000434	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.63e-05	0.000434	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.63e-05	0.000434	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.63e-05	0.000434	CbGpPWpGaD
Ropinirole—ADRA2B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.62e-05	0.000432	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.6e-05	0.000428	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.6e-05	0.000428	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.6e-05	0.000428	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.59e-05	0.000428	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.59e-05	0.000428	CbGpPWpGaD
Ropinirole—DRD5—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.55e-05	0.000421	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.55e-05	0.000421	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.55e-05	0.000421	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.55e-05	0.00042	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.53e-05	0.000418	CbGpPWpGaD
Ropinirole—HTR1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.53e-05	0.000417	CbGpPWpGaD
Ropinirole—HTR2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.51e-05	0.000414	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.51e-05	0.000414	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.5e-05	0.000411	CbGpPWpGaD
Ropinirole—DRD2—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	2.49e-05	0.000411	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.46e-05	0.000406	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.46e-05	0.000406	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.45e-05	0.000403	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.44e-05	0.000403	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	2.44e-05	0.000403	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.44e-05	0.000402	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.44e-05	0.000402	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.43e-05	0.0004	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.43e-05	0.0004	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.42e-05	0.000399	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.41e-05	0.000398	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.41e-05	0.000397	CbGpPWpGaD
Ropinirole—ADRA2B—Hemostasis—IL2—acquired immunodeficiency syndrome	2.39e-05	0.000395	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.39e-05	0.000393	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.38e-05	0.000392	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.37e-05	0.000391	CbGpPWpGaD
Ropinirole—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.33e-05	0.000384	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.33e-05	0.000383	CbGpPWpGaD
Ropinirole—DRD5—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.32e-05	0.000383	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.31e-05	0.000381	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.3e-05	0.000379	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.3e-05	0.000379	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.29e-05	0.000378	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.28e-05	0.000376	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.27e-05	0.000374	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.27e-05	0.000374	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.25e-05	0.000371	CbGpPWpGaD
Ropinirole—ADRA2A—Hemostasis—ALB—acquired immunodeficiency syndrome	2.24e-05	0.000369	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.24e-05	0.000369	CbGpPWpGaD
Ropinirole—ADRA2C—Hemostasis—IL2—acquired immunodeficiency syndrome	2.23e-05	0.000369	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.22e-05	0.000366	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.22e-05	0.000366	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	2.22e-05	0.000366	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.2e-05	0.000363	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.2e-05	0.000363	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.2e-05	0.000363	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.18e-05	0.00036	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.18e-05	0.000359	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.17e-05	0.000358	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.17e-05	0.000357	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.1e-05	0.000347	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.09e-05	0.000345	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.05e-05	0.000338	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.05e-05	0.000338	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.04e-05	0.000337	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.04e-05	0.000336	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.02e-05	0.000333	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.01e-05	0.000332	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.01e-05	0.000331	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2e-05	0.00033	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.99e-05	0.000328	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.99e-05	0.000327	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.98e-05	0.000327	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.98e-05	0.000326	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.98e-05	0.000326	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.97e-05	0.000326	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.97e-05	0.000325	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.97e-05	0.000324	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.97e-05	0.000324	CbGpPWpGaD
Ropinirole—HTR1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.96e-05	0.000323	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.95e-05	0.000321	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.94e-05	0.00032	CbGpPWpGaD
Ropinirole—HTR1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.92e-05	0.000316	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.91e-05	0.000316	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.91e-05	0.000315	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.91e-05	0.000315	CbGpPWpGaD
Ropinirole—DRD4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.89e-05	0.000311	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	1.89e-05	0.000311	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.85e-05	0.000306	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.85e-05	0.000304	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.83e-05	0.000301	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.83e-05	0.000301	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.82e-05	0.0003	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.82e-05	0.0003	CbGpPWpGaD
Ropinirole—ADRA2A—Hemostasis—IL2—acquired immunodeficiency syndrome	1.82e-05	0.000299	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.8e-05	0.000297	CbGpPWpGaD
Ropinirole—HTR2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.8e-05	0.000297	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.78e-05	0.000293	CbGpPWpGaD
Ropinirole—HTR1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.78e-05	0.000293	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.75e-05	0.000289	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.75e-05	0.000288	CbGpPWpGaD
Ropinirole—HTR1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.74e-05	0.000287	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.74e-05	0.000286	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.74e-05	0.000286	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.73e-05	0.000285	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.72e-05	0.000284	CbGpPWpGaD
Ropinirole—DRD4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.71e-05	0.000282	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.71e-05	0.000282	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.71e-05	0.000282	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.7e-05	0.00028	CbGpPWpGaD
Ropinirole—DRD1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.7e-05	0.00028	CbGpPWpGaD
Ropinirole—DRD3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.67e-05	0.000276	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.67e-05	0.000276	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.65e-05	0.000273	CbGpPWpGaD
Ropinirole—HTR2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.63e-05	0.00027	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.58e-05	0.00026	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.56e-05	0.000257	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.55e-05	0.000256	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.55e-05	0.000256	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.55e-05	0.000256	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.54e-05	0.000254	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.53e-05	0.000253	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.52e-05	0.000251	CbGpPWpGaD
Ropinirole—ADRA2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.51e-05	0.000249	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.5e-05	0.000248	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.5e-05	0.000247	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.48e-05	0.000244	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.47e-05	0.000243	CbGpPWpGaD
Ropinirole—HTR1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.46e-05	0.000241	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.46e-05	0.00024	CbGpPWpGaD
Ropinirole—HTR2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.45e-05	0.000239	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.43e-05	0.000236	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.41e-05	0.000233	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.4e-05	0.000231	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.37e-05	0.000226	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.37e-05	0.000226	CbGpPWpGaD
Ropinirole—DRD5—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.36e-05	0.000225	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.36e-05	0.000223	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.35e-05	0.000222	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.33e-05	0.000219	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.32e-05	0.000218	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.32e-05	0.000217	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.31e-05	0.000216	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.3e-05	0.000215	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.3e-05	0.000214	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.28e-05	0.000211	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.28e-05	0.000211	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.28e-05	0.000211	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.26e-05	0.000208	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.19e-05	0.000196	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.18e-05	0.000195	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.17e-05	0.000193	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.16e-05	0.000192	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.16e-05	0.000192	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.15e-05	0.000189	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.15e-05	0.000189	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.13e-05	0.000186	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—ALB—acquired immunodeficiency syndrome	1.12e-05	0.000184	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.07e-05	0.000176	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.05e-05	0.000173	CbGpPWpGaD
Ropinirole—HTR1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.04e-05	0.000172	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.04e-05	0.000172	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.03e-05	0.000169	CbGpPWpGaD
Ropinirole—HTR1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.02e-05	0.000169	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.01e-05	0.000167	CbGpPWpGaD
Ropinirole—DRD4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.01e-05	0.000166	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.66e-06	0.000159	CbGpPWpGaD
Ropinirole—HTR2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.61e-06	0.000158	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.11e-06	0.00015	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—ALB—acquired immunodeficiency syndrome	9.08e-06	0.00015	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.06e-06	0.000149	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.98e-06	0.000148	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.94e-06	0.000147	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.11e-06	0.000134	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.07e-06	0.000133	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—IL6—acquired immunodeficiency syndrome	8.06e-06	0.000133	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.83e-06	0.000129	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.79e-06	0.000128	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.79e-06	0.000128	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.75e-06	0.000128	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.58e-06	0.000125	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.54e-06	0.000124	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.88e-06	0.000113	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.84e-06	0.000113	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.76e-06	0.000112	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.73e-06	0.000111	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.17e-06	0.000102	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.15e-06	0.000101	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.12e-06	0.000101	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.04e-06	9.96e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.95e-06	9.8e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	5.91e-06	9.75e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.68e-06	9.36e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.35e-06	8.83e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.28e-06	8.71e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	5.01e-06	8.26e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.77e-06	7.86e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.6e-06	7.59e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.58e-06	7.55e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.45e-06	7.34e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.04e-06	6.66e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.98e-06	6.56e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	3.87e-06	6.38e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.62e-06	5.96e-05	CbGpPWpGaD
